What is Ublituximab?

Category: Prescription Drugs

false

Ublituximab is a monoclonal antibody that has been developed for the treatment of B-cell proliferative disorders but may also be used to treat a variety of autoimmune conditions.

Dosages

Based on patients currently taking Ublituximab

Dosage Patients
1 mg daily 1
450 mg every 6 months 1

Duration

Currently taking Ublituximab

Duration Patients
6 months - 1 year 1
1 - 2 years 1

What people switch to and from

Patients started taking Ublituximab after stopping:

Treatment Patients
Glatiramer acetate (Copaxone) 1
Last updated:
There are no evaluations for Ublituximab.